Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (241-250 of 721) with videos related to

Pageof 73
Sort By:
BMC Cancer|December 25, 2015
Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CTKen Herrmann, Marcelo Queiroz, Martin W Huellner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 31, 2022
A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) CollaborativeIrfan Vardarli, Tim Brandenburg, Laszlo Hegedüs, et al.
Nuclear Medicine Communications|September 10, 2016
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patientsMartin Barrio, Johannes Czernin, Michael W Yeh, et al.
Clinical Imaging|March 20, 2018
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: Preliminary resultsTheresia Sarabhai, Alexander Tschischka, Vanessa Stebner, et al.
Nuclear Medicine and Biology|August 6, 2008
[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancerMurat Tuncel, Michael Souvatzoglou, Ken Herrmann, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 26, 2021
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom studyPedro Fragoso Costa, Walter Jentzen, Finja SÜßELBECK, et al.
BMC Cancer|December 24, 2017
Diagnostic accuracy of <sup>18</sup>F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinomaVerena Ruhlmann, Thorsten D Poeppel, Johannes Veit, et al.
Cancers|August 26, 2023
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of SurvivalAglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2023
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRTManuel Weber, Olof Pettersson, Robert Seifert, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Correction: Pacelli et al. Fully Automated, High-Dose Radiosynthesis of [18F]PARPi. <i>Pharmaceuticals</i> 2022, <i>15</i>, 865Anna Pacelli, Fadi Zarrad, Corentin Warnier, et al.
Pageof 73

Showing results (241-250 of 721) with videos related to

Sort By:
Pageof 73
BMC Cancer|December 25, 2015
Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CTKen Herrmann, Marcelo Queiroz, Martin W Huellner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 31, 2022
A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) CollaborativeIrfan Vardarli, Tim Brandenburg, Laszlo Hegedüs, et al.
Nuclear Medicine Communications|September 10, 2016
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patientsMartin Barrio, Johannes Czernin, Michael W Yeh, et al.
Clinical Imaging|March 20, 2018
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: Preliminary resultsTheresia Sarabhai, Alexander Tschischka, Vanessa Stebner, et al.
Nuclear Medicine and Biology|August 6, 2008
[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancerMurat Tuncel, Michael Souvatzoglou, Ken Herrmann, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 26, 2021
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom studyPedro Fragoso Costa, Walter Jentzen, Finja SÜßELBECK, et al.
BMC Cancer|December 24, 2017
Diagnostic accuracy of <sup>18</sup>F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinomaVerena Ruhlmann, Thorsten D Poeppel, Johannes Veit, et al.
Cancers|August 26, 2023
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of SurvivalAglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2023
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRTManuel Weber, Olof Pettersson, Robert Seifert, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Correction: Pacelli et al. Fully Automated, High-Dose Radiosynthesis of [18F]PARPi. <i>Pharmaceuticals</i> 2022, <i>15</i>, 865Anna Pacelli, Fadi Zarrad, Corentin Warnier, et al.
Pageof 73